Skip to main content
PNTG
NASDAQ Industrial Applications And Services

Pennant Group Q2 Revenue Jumps 36% to $298M, EPS $0.25; Home Health and Hospice Drive Growth

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$38.89
Mkt Cap
$1.349B
52W Low
$21.835
52W High
$42.69
52W Position info
78% above low
Off High info
8.9% below high
Rel. Volume info
2.2× avg
Market data snapshot near publication time

PNTG sits 78% above its 52-week low of $21.835 on elevated volume (2.2× avg).

Summary

Pennant Group reported Q2 2026 revenue of $298 million, up 35.8% year-over-year, with net income of $9.1 million. Home health and hospice led growth, while debt rose to fund acquisitions.


Key Events · Earnings and Guidance · PNTG

  • Revenue Surges 36% to $298M

    Q2 2026 revenue reached $298.0 million, a 35.8% increase from $219.5 million in Q2 2025, driven by a 43.2% jump in home health and hospice services.

  • Earnings Rise 28% to $9.1M

    Net income attributable to Pennant Group was $9.1 million, or $0.25 per diluted share, compared to $7.1 million, or $0.20 per share, a year ago.

  • Home Health and Hospice Leads Growth

    Home health and hospice segment revenue climbed 43.2% to $237.8 million, with total home health admissions up 62.3% and hospice average daily census up 40.1%.

  • Operating Cash Flow Strengthens

    Cash provided by operating activities was $18.4 million for the first six months of 2026, up from $13.4 million in the prior-year period, supporting acquisition funding.


Analysis · PNTG · Industrial Applications And Services

A standout second quarter saw revenue surge 35.8% to $298 million, while net income attributable to Pennant climbed 28.2% to $9.1 million. The home health and hospice segment was the clear engine, expanding revenue 43.2% year-over-year on the back of acquisitions and higher admissions. Operating cash flow strengthened 37% to $18.4 million in the first half, though debt rose to $198.5 million to fuel that growth. The results confirm that the company's acquisition-driven expansion strategy is delivering meaningful top- and bottom-line gains, but higher leverage and integration costs warrant monitoring.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PNTG was trading at $38.89 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $21.84 to $42.69. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PNTG - Latest Insights

PNTG
Nov 04, 2026, 4:19 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $40.30
Real-time Price: $35.81 info
Change: -$4.49 (-11%) info
Market Cap: $1.258B info
PNTG
Nov 04, 2026, 4:13 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $41.21
Real-time Price: $35.81 info
Change: -$5.40 (-13%) info
Market Cap: $1.258B info
PNTG
Nov 04, 2026, 4:05 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $44.04
Real-time Price: $35.81 info
Change: -$8.23 (-19%) info
Market Cap: $1.258B info
PNTG
Sep 16, 2026, 4:30 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $42.35
Real-time Price: $35.81 info
Change: -$6.54 (-15%) info
Market Cap: $1.258B info
PNTG
Aug 04, 2026, 4:00 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $38.67
Real-time Price: $35.81 info
Change: -$2.85 (-7%) info
Market Cap: $1.258B info